Skip to main content
NATCO Pharma Limited (NSE:NATCOPHARM)
India flag India · Delayed Price · Currency is INR
1,002.70
-17.00 (-1.67%)
At close: Mar 9, 2026

NATCO Pharma Revenue

NATCO Pharma had revenue of 6.47B INR in the quarter ending December 31, 2025, with 36.33% growth. This brings the company's revenue in the last twelve months to 45.63B, up 6.60% year-over-year. In the fiscal year ending March 31, 2025, NATCO Pharma had annual revenue of 44.32B with 10.74% growth.

Revenue (ttm)
45.63B
Revenue Growth
+6.60%
P/S Ratio
3.94
Revenue / Employee
10.87M
Employees
4,199
Market Cap
179.59B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Mar 31, 202544.32B4.30B10.74%
Mar 31, 202440.02B12.94B47.76%
Mar 31, 202327.09B7.62B39.17%
Mar 31, 202219.46B-1.10B-5.35%
Mar 31, 202120.56B1.41B7.37%
Mar 31, 2020 Pro Pro Pro
Mar 31, 2019 Pro Pro Pro
Mar 31, 2018 Pro Pro Pro
Mar 31, 2017 Pro Pro Pro
Mar 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Eris Lifesciences 30.65B
Piramal Pharma 88.71B
Wockhardt 31.74B
Alembic Pharmaceuticals 72.67B
Emcure Pharmaceuticals 88.50B
Gland Pharma 61.13B
Alivus Life Sciences 25.12B
Cohance Lifesciences 10.79B
Revenue Rankings

NATCO Pharma News

More News